Replies to post #22527 on Relief Therapeutics Holding AG (RLFTF)

[nelskof]

Everyone is allowed to have their opinion. I remember you trying to find out how to get Aviptadil for your father. (I think that was you and I pray he's doing great!) Think about how many people all over the world are going to be doing the same thing you were! The virus is mutating, it's scientifically proven to be way worse than the flu so I'm not going to debate that. Hopefully, we get a handle on it over the next year or two but there is a massive global market for RLF-100 and that isn't going away any time soon.

EUA is in the hands of the FDA. That has always been what us longs are waiting for. They may want to see the trial data before authorizing and that is coming up soon too. When the FDA gives Relief/Neuro an EUA this sucker will run. If it doesn't then I will come back here and say you were 100% right. Even if it doesn't run as high as I think it will I don't think we are likely to suffer major losses unless it gets outright denied. For that part, I trust the science, Dr. Javitt and his team.

[weathervane]

They don't listen to reason.

[nyy13]

yup ive mentioned several times...sector play. get in, get out. never hold. same ol story. people freak out b/c of fear of the unknown. people will always die, just like they die from the flu but immunity will be slowly built to it overtime.

[Tiger Money]

I hear ya but Microsoft has 7,500,000,000 shares, yes, 7.5 billion shares outstanding. They created the software biz along with Apple and rlftf created a therapeutic to help save people or about 7.5 billion people. If that ends up being the case, which most believe, they could still dilute by another billion shares and this stock price would still be 3-5x from here

[mcjodie]

Depends on perspective. I have plenty of stocks that I play and I would agree on the MJ, block chain etc comments. I also have many I hold almost on the forever plan, and then I have some I am long on (at least more than 6 months).
This is one of them. If you are thinking of this as a Covid stock, then we simply aren’t on the same page and therefor our perspectives are different. This stock will either do incredibly well because the drug does well after all trials are done, or the trials won’t end well and the gamble won’t pay off. The reason that the share information doesn’t matter to me, is that it will get bought by one of the big 10 pharma companies. That’s the gamble I am waiting on. Take profits along the way to cover your initial investment and then sit and wait...